Knockout of THBS1 gene improves immune microenvironment of visceral fat and inhibits intraperitoneal implantation and metastasis of colorectal cancer in mice

Teng WANG; Yuan GAO; Kun ZHAO; Yuancai XIANG; Hongming MIAO

doi:10.16016/j.2097-0927.202303119

您当前的位置：

首页 >

文章列表页 >

Knockout of THBS1 gene improves immune microenvironment of visceral fat and inhibits intraperitoneal implantation and metastasis of colorectal cancer in mice

Basic Medicine | 更新时间：2026-01-09

- Knockout of THBS1 gene improves immune microenvironment of visceral fat and inhibits intraperitoneal implantation and metastasis of colorectal cancer in mice
- Journal of Army Medical University Vol. 45, Issue 18, Pages: 1907-1915(2023)
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)高原军事医学系病理生理学教研室
  2.646000 四川泸州，西南医科大学基础医学院生物化学与分子生物学教研室
- 作者简介：
- 基金信息：
  
  the General Program of National Science Foundation of China(82173134)
- DOI：10.16016/j.2097-0927.202303119
  CLC： R392.32;R394.3;R735.35
- Received：20 March 2023，
  
  Revised：2023-05-26，
  
  Published：30 September 2023
- 稿件说明：
移动端阅览
Teng WANG, Yuan GAO, Kun ZHAO, et al. Knockout of THBS1 gene improves immune microenvironment of visceral fat and inhibits intraperitoneal implantation and metastasis of colorectal cancer in mice[J]. Journal of Army Medical University, 2023, 45(18): 1907-1915.
DOI：

Teng WANG, Yuan GAO, Kun ZHAO, et al. Knockout of THBS1 gene improves immune microenvironment of visceral fat and inhibits intraperitoneal implantation and metastasis of colorectal cancer in mice[J]. Journal of Army Medical University, 2023, 45(18): 1907-1915. DOI： 10.16016/j.2097-0927.202303119.

摘要

目的

探究血小板反应蛋白1(thrombospondin-1，THBS1)基因敲除对结直肠癌免疫微环境与肿瘤进展的作用。

方法

构建THBS1基因敲除小鼠，经PCR、琼脂糖凝胶电泳明确小鼠基因型。用THBS1基因野生型(THBS1

+/+

)与THBS1基因敲除(THBS1

-/-

)小鼠构建结直肠癌皮下荷瘤与腹腔种植转移模型，观察THBS1基因敲除对小鼠肿瘤生长情况的影响。用流式细胞术检测腹腔种植转移模型中THBS1基因敲除后对结直肠癌附睾脂肪中免疫细胞的变化。

结果

与THBS1

+/+

小鼠相比，THBS1

-/-

小鼠在结肠癌皮下荷瘤模型中肿瘤生长没有差异(

0.05)，而在腹腔种植转移模型中则显著抑制肿瘤生长(

0.05)。流式细胞术检测结果显示，与THBS1

+/+

小鼠相比，THBS1基因敲除后腹腔种植转移模型小鼠的附睾脂肪组织中总巨噬细胞比例增高(

0.01)，其中M1型(经典型或促炎型)巨噬细胞比例升高(

0.01)、M2型(替代活化型或抗炎型)巨噬细胞比例下降(

0.01)；髓源性抑制细胞(myeloid-derived suppressor cells，MDSC)比例下降(

0.05)，其中Ly6C亚群(

0.01)比例升高，Ly6G亚群比例降低(

0.05)；CD8

T细胞比例显著升高(

0.01)、CD4

T细胞比例降低(

0.01)。与THBS1

+/+

小鼠相比，THBS1基因敲除小鼠外周血总巨噬细胞、M1型巨噬细胞、M2型巨噬细胞比例均无变化(

0.05)；MDSC及ly6C亚群比例无变化(

0.05)，ly6G亚群比例降低(

0.05)；CD8

T细胞比例显著降低(

0.05)、CD4

T细胞比例无变化(

0.05)。

结论

THBS1基因敲除通过增强肿瘤免疫抑制结直肠癌细胞腹腔种植转移。

Abstract

Objective

To investigate the effects of thrombospondin1 (THBS1) gene knockout on immune microenvironment and tumor progression of colorectal cancer.

Methods

THBS1 gene knockout (THBS1

-/-

) mice were constructed and its genotypes were determined by PCR and agarose gel electrophoresis. Subcutaneous tumor bearing and intraperitoneal implantation metastasis models of colorectal cancer were constructed in wild type (WT) and THBS1

-/-

mice to observe the effect of THBS1 on tumor growth. Immune cells in epididymal adipose of tumor bearing mice of both types were detected by flow cytometry.

Results

Compared with the WT mice

THBS1

-/-

mice showed no difference in tumor growth in colorectal cancer subcutaneous tumor bearing model (

0.05)

but significantly inhibited tumor growth in intraperitoneal implantation metastasis model (

0.05). Subsequently

flow cytometry indicated that the proportion of total macrophages in the epididymal adipose tissue was increased in the THBS1

-/-

mice than the WT mice (

0.01)

with the proportion of M1-like macrophages (typical or proinflammatory type) increased (

0.01) and that of M2-like macrophages (alternately activated or anti-inflammatory type) decreased (

0.01). The proportion of myeloid-derived suppressor cells (MDSC) was decreased (

0.05)

that of L

y6C subgroup was increased (

0.01)

that of Ly6G subgroup was decreased (

0.05)

that of CD8

T cells was significantly increased (

0.01)

and that of CD4

T cells was decreased (

0.01). There were no changes in the proportions of total macrophages

M1-like macrophages and M2-like macrophages in the peripheral blood of intraperitoneal implantation metastasis model mice (

0.05). The proportions of MDSC and ly6C subgroup were not changed (

0.05)

while that of ly6G subgroup were decreased (

0.05). The proportion of CD8

T cells was significantly decreased (

0.05)

while that of CD4

T cells was not changed (

0.05).

Conclusion

THBS1 gene knockout inhibits the intraperitoneal metastasis of colorectal cancer cells by enhancing tumor immunity.

关键词

Keywords

references

BILLER L H, SCHRAG D. Diagnosis and treatment of metastatic colorectal cancer: a review[J]. JAMA, 2021, 325(7): 669-685. DOI: 10.1001/jama.2021.0106.

XIE Y H, CHEN Y X, FANG J Y. Comprehensive review of targeted therapy for colorectal cancer[J]. Signal Transduct Target Ther, 2020, 5(1): 22. DOI: 10.1038/s41392-020-0116-z.

XIANG W, SHI R C, ZHANG D P, et al . Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages[J ] . Signal Transduct Target Ther, 2020, 5(1): 239. DOI: 10.1038/s41392-020-00327-z.

KAUR S, BRONSON S M, PAL-NATH D, et al . Functions of thrombospondin-1 in the tumor microenvironment[J ] . IntJ Mol Sci, 2021, 22(9): 4570. DOI: 10.3390/ijms22094570.

CARPINO G, CARDINALE V, DI GIAMBERARDINO A, et al . Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangio-carcinoma[J ] . J Hepatol, 2021, 75(6): 1377-1386. DOI: 10.1016/j.jhep.2021.07.016.

DAUBON T, LÉON C, CLARKE K, et al . Deciphering the complex role of thrombospondin-1 in glioblastoma development[J ] . Nat Commun, 2019, 10(1): 1146. DOI: 10.1038/s41467-019-08480-y.

PATWARDHAN S, MAHADIK P, SHETTY O, et al . ECM stiffness-tuned exos omes drive breast cancer motility through thrombospondin-1[J ] . Biomaterials, 2021, 279: 121185. DOI: 10.1016/j.biomaterials.2021.121185.

SHEN J, CAO B, WANG Y, et al . Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer[J ] . J Exp Clin Cancer Res, 2018, 37(1): 175. DOI: 10.1186/s13046-018-0850-z.

WU CC, LI M N, MENG H B, et al . Analysis of status and countermeasures of cancer incidence and mortality in China[J ] . Sci China Life Sci, 2019, 62(5): 640-647. DOI: 10.1007/s11427-018-9461-5.

FAN A H, WANG B D, WANG X, et al . Immunotherapy in colorectal cancer: current achievements and future perspective[J ] . Int J Biol Sci, 2021, 17(14): 3837-3849. DOI: 10.7150/ijbs.64077.

XIAO Y, YU D H. Tumor microenvironment as a therapeutic target in cancer[J]. Pharmacol Ther, 2021, 221: 107753. DOI: 10.1016/j.pharmthera.2020.107753.

SHI R, XIANG W, KANG X, et al . Alteration of adaptive immunity in a colorectal peritoneal carcinomatosis model[J ] . J Cancer, 2019, 10(2): 367-377. DOI: 10.7150/jca.27947.

袁静, 缪洪明. 肿瘤相关巨噬细胞MGLL缺失促进免疫抑制和结直肠癌细胞腹腔种植转移[J]. 陆军军医大学学报, 2023, 45(6): 530-538. DOI:10.16016/j.2097-0927.202209246.

YUAN J, MIAO H M. MGLL deficiency in tumor-associated macrophages promotes immunosuppression and colorectal peritoneal metastases in mice[J]. J Army Med Univ, 2023, 45(6): 530-538. DOI:10.16016/j.2097-0927.202209246.

LI X G, YAO W B, YUAN Y, et al . Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma[J ] . Gut, 2017, 66(1): 157-167. DOI: 10.1136/gutjnl-2015-310514.

ANDERSON NR, MINUTOLO NG, GILL S, et al . Macrophage-based approaches for cancer immunotherapy[J ] . Cancer Res, 2021, 81(5): 1201-1208. DOI: 10.1158/0008-5472.CAN-20-2990.

GABRILOVICH D I, OSTRAND-ROSENBERG S, BRONTE V. Coordinated regulation of myeloid cells by tumours[J]. Nat Rev Immunol, 2012, 12(4): 253-268. DOI: 10.1038/nri3175.

TANAKA A, SAKAGUCHI S. Regulatory T cells in cancer immunotherapy[J]. Cell Res, 2017, 27(1): 109-118. DOI: 10.1038/cr.2016.151.

BORST J, AHRENDS T, BĄABAŁA N, et al . CD4 + T cell help in cancer immunology and immuno therapy[J ] . Nat Rev Immunol, 2018, 18(10): 635-647. DOI: 10.1038/s41577-018-0044-0..

MILLER T W, KAUR S, IVINS-O'KEEFE K, et al . Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation[J ] . Matrix Biol, 2013, 32(6): 316-324. DOI: 10.1016/j.matbio.2013.02.009.

XIAO M, ZHANG JJ, CHEN W J, et al . M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma[J ] . J Exp Clin Cancer Res, 2018, 37(1): 143. DOI: 10.1186/s13046-018-0815-2.

NATH P R, PAL-NATH D, MANDAL A, et al . Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment[J ] . Cancer Immunol Res, 2019, 7(9): 1547-1561. DOI: 10.1158/2326-6066.CIR-18-0367.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

MiR-543/SNTB1 axis modulates immune microenvironment in colorectal cancer

Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer

Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells

Plateau hypoxia improves tumor immune microenvironment and inhibits subcutaneous tumor growth of colorectal cancer

Value of energy spectrum CT volume quantitative parameters in differentiating pathological types of colorectal cancer

Related Author

ZHANG Min

LI Min

XIAO Meng

CHEN Cai

ZHENG Xiaoju

LEI Yuguang

ZHAO Wensi

SONG Jian

Related Institution

School of Medicine, Xinyang Hospital of Traditional Chinese Medicine

School of Pharmaceutical Sciences， Xinyang Vocational and Technical College， Xinyang， Henan, Xinyang Hospital of Traditional Chinese Medicine

Department of Pathology, Xinyang Hospital of Traditional Chinese Medicine

Department of Oncology, Renmin Hospital of Wuhan University

Department of Pharmacy, Renmin Hospital of Wuhan University

⁰